Analgesic efficacy and safety of epidural oxycodone in patients undergoing total hip arthroplasty: a pilot study
Received 24 June 2017
Accepted for publication 28 August 2017
Published 27 September 2017 Volume 2017:10 Pages 2303—2309
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Dr Michael Schatman
BogumiĹ‚ Olczak,1 Grzegorz Kowalski,1,2 Wojciech Leppert,2 Agnieszka Bienert,3 Artur TeĹĽyk,4 MichaĹ‚ Adamski,1 StanisĹ‚aw Rzymski,1 Katarzyna Wieczorowska-Tobis2
1Department of Anaesthesiology, Józef StruĹ› Multiprofile Municipal Hospital, PoznaĹ„, 2Department of Palliative Medicine, 3Department of Clinical Pharmacy and Biopharmacy, 4Department of Forensic Medicine, Poznan University of Medical Sciences, PoznaĹ„, Poland
Background and objectives: Oxycodone is poorly studied as an adjuvant to central blockades. The aim of this pilot study was to assess the efficacy and safety of oxycodone hydrochloride in epidural blockade among patients undergoing total hip arthroplasty (THA).
Patients and methods: In 11 patients (American Society of Anesthesiologists physical status classification system II/III, age range: 59–82 years), THA was conducted with an epidural blockade using 15 mL 0.25% bupivacaine (37.5 mg) with 5 mg oxycodone hydrochloride and sedation with propofol infusion at a dose of 3–5 mg/kg/h. After the surgery, patients received ketoprofen at a dose of 100 mg twice daily. In the first 24 hours postoperative period, pain was assessed by numerical rating scale at rest and on movement; adverse effects (AEs) were recorded; and plasma concentrations of oxycodone, noroxycodone, and bupivacaine were measured.
Results: The administration of epidural oxycodone at a dose of 5 mg in patients undergoing THA provided analgesia for a mean time of 10.3±4.89 h. In one patient, mild pruritus was observed. Oxycodone did not evoke other AEs. Plasma concentrations of oxycodone while preserving analgesia were >2.9 ng/mL. Noroxycodone concentrations in plasma did not guarantee analgesic effect.
Conclusion: The administration of epidural oxycodone at a dose of 5 mg prolongs the analgesia period to ~10 hours in patients after THA. Oxycodone may evoke pruritus. A 5 mg dose of oxycodone hydrochloride used in an epidural blockade seems to be a safe drug in patients after THA.
Keywords: analgesia, oxycodone, pain, total hip arthroplasty
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Other articles by this author:
A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D
Published Date: 22 August 2017
Analgesic efficacy, adverse effects, and safety of oxycodone administered as continuous intravenous infusion in patients after total hip arthroplasty
Olczak B, Kowalski G, Leppert W, Zaporowska-Stachowiak I, Wieczorowska-Tobis K
Published Date: 4 May 2017
Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain
Leppert W, Kowalski G
Published Date: 4 December 2015
Published Date: 16 April 2015
Quality of life assessment in advanced cancer patients treated at home, an inpatient unit, and a day care center
Leppert W, Majkowicz M, Forycka M, Mess E, Zdun-Ryzewska A
Published Date: 8 May 2014
Published Date: 30 September 2010